All lobbying filings

INNOVATIVE FEDERAL STRATEGIES, LLC

Lobbying for X-BIOTIX THERAPEUTICS, INC. · biotechnology company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Budget/Appropriations

H.R.____/S.____, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Title II, all provisions related to Antimicrobial Resistance.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.